- Location
metastatic
"-
The Company's Robust Performance Was Driven by New and Existing Drug Sales
Apr 16, 2014The common stock of healthcare and medical device giant Johnson & Johnson (JNJ) soared to recent highs following the company's announcement of first quarter results that beat analysts' estimates. The company's robust performance was ...
Tags: Health, Medicine, medical device
-
Elderly Kidney Cancer Patients Benefit From Sunitinib Therapy
Feb 27, 2014By Sara Freeman, medwireNews Reporter Elderly kidney cancer patients benefit from sunitinib therapy just as much as their younger counterparts, a retrospective analysis of six clinical trials shows. Median progression-free survival ...
Tags: PFS, mRCC, Advanced Age, IFN
-
Patients with Advanced Renal Cell Carcinoma Are on and off Treatment
Feb 27, 2014By Sara Freeman, medwireNews Reporter mewireNews: Shortening the time that patients with advanced renal cell carcinoma are on and off treatment with sunitinib improves the drug’s overall tolerability without affecting its efficacy, ...
Tags: ORR, Tolerability, PFS, Sunitinib
-
Advanced Breast Cancer Has Identified Individuals with a Good Chance
Feb 25, 2014The first large-scale study testing all the DNA—the entire genome—of tumour cells from more than 400 women with advanced breast cancer has identified individuals with a good chance of benefiting from specific treatments already ...
Tags: CGH, SAFIR01, DNA, Gustave Roussy
-
Article Cites Potential to Save Money on End-of-Life Care, Medical Imaging and Drug Price
Feb 17, 2014Article cites potential to save money on end-of-life care, medical imaging and new drug prices In a review article published Feb. 14 in The Lancet Oncology, Johns Hopkins experts identify three major sources of high cancer costs and argue ...
-
Study Finds Improvements in Survival Largely Reflect Gains Among Non-Elderly Whites
Feb 16, 2014Study finds improvements in survival largely reflect gains among non-elderly whites and Asians While new and better treatments have improved the odds of survival for patients diagnosed late stage colorectal cancer, that progress has been ...
-
Incyte Has Entered Into a Agreement with Merck Through a Merck Subsidiary
Feb 14, 2014Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 ...
Tags: collaboration agreement, Incyte's oral indoleamine dioxygenase-1, IDO1
-
Palbociclib Received Breakthrough Therapy Designation by The United States Food
Feb 14, 2014Pfizer Inc. (NYSE:PFE) today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival ...
Tags: Health&Medicine
-
There's More Good News Than One Might Expect
Feb 8, 2014The Washington Post: Making Progress On Inequality Intense as it is, the current debate over rising income inequality is hardly new. ... The good news is that there's more good news than one might expect. ... In addition to avoiding ...
Tags: ACA, Obamacare, medical care, health overhaul
-
Researchers Identified Critical Complex Mechanisms Involved in The Metastasis of Deadly
Jan 20, 2014A team of researchers from the Cleveland Clinic and Case Western Reserve School of Medicine have identified critical complex mechanisms involved in the metastasis of deadly "triple negative" breast cancers (TNBC). These tumors are extremely ...
Tags: Life-Saving Treatments, ight Tumor Metastasis, Life-Saving
-
Developing Oncology Companion Diagnostic Test Was Agreed by Amgen and Illumina
Jan 17, 2014Illumina has entered into an agreement with Amgen to develop and commercialize a multigene, NGS-based test as a companion diagnostic for Vectibix (panitumumab), a fully human anti-EGFR monoclonal antibody therapeutic for the treatment of ...
Tags: Amgen, FDA, CE, Illumina Oncology
-
Breast Cancer Stem Cells Exist in Two Different States
Jan 15, 2014Breast cancer stem cells exist in two different states and each state plays a role in how cancer spreads, according to an international collaboration of researchers. Their finding sheds new light on the process that makes cancer a deadly ...
-
FDA Has Approved GlaxoSmithKline's Use of Mekinist in Combination with Tafinlar
Jan 13, 2014The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's (GSK) use of Mekinist (trametinib) in combination with Tafinlar (dabrafenib) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF ...
Tags: FDA, Combination Drug
-
FDA Approved Mekinist, or Trametinib, in Combination with Tafinlar
Jan 10, 2014The U.S. Food and Drug Administration approved Mekinist, or trametinib, in combination with Tafinlar, or dabrafenib, to treat patients with advanced melanoma. Dr. Richard Pazdur, director of the Office of Hematology and Oncology Products ...
Tags: Skin Cancer, Health, Medicine
-
Adding Cancer Drug Dasatinib to Therapy May Slow Progression of Advanced Breast Cancer
Dec 26, 2013Adding the cancer drug dasatinib to standard hormone therapy may slow the progression of advanced breast cancer, a preliminary study suggests. The drug, sold under the name Sprycel, is already approved in the United States for chronic ...
Tags: cancer drug, dasatinib, hormone therapy, advanced breast cancer
